AltraVue Capital
AltraVue Capital reported 26 stocks worth $1.4B in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are SNEX (11.8%), VSEC (8.5%) and TFIN (7.7%). Compared with Q1 2026, the fund opened new positions in ECVT, added to WINA, AGYS and NYAX, trimmed SNEX, VSEC and TFIN and sold out of TRIP and NOMD.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  SNEX Stonex Group Inc | $163M | 11.8% | 1.4M | −252K (−15%) | 8 of 8 | |
| 2 |  VSEC Vse Corp | $117M | 8.5% | 514K | −11K (−2%) | 8 of 8 | |
| 3 |  TFIN Triumph Financial Inc | $107M | 7.7% | 1.4M | −27K (−2%) | 8 of 8 | |
| 4 |  PLUS Eplus Inc | $75.8M | 5.5% | 911K | −16K (−2%) | 8 of 8 | |
| 5 |  WINA Winmark Corp | $72.9M | 5.3% | 172K | +11K (+6%) | 8 of 8 | |
| 6 |  AGX Argan Inc | $72.2M | 5.2% | 90K | −21K (−19%) | 8 of 8 | |
| 7 |  ULS UL Solutions Inc | $71.5M | 5.2% | 702K | No change | 8 of 8 | |
| 8 |  IESC Ies Hldgs Inc | $70.8M | 5.1% | 96K | −33K (−26%) | 8 of 8 | |
| 9 |  UNH Unitedhealth Group Inc | $58.9M | 4.3% | 142K | No change | 8 of 8 | |
| 10 |  AGYS Agilysys Inc | $57.7M | 4.2% | 553K | +147K (+36%) | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 13, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →AltraVue Capital 13F FAQ
What does AltraVue Capital own?
AltraVue Capital reported 26 stocks worth $1.4B in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are SNEX (11.8%), VSEC (8.5%) and TFIN (7.7%). The table above lists every position in the filing (the top 10 without an account).
What did AltraVue Capital buy and sell in Q2 2026?
Compared with Q1 2026: 1 new positions, 5 added to, 15 trimmed and 2 sold out. New positions include ECVT. It sold all of TRIP and NOMD.
When will AltraVue Capital file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is AltraVue Capital's portfolio worth?
The Q2 2026 filing reports $1.4B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.